Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T19:43:51.134Z.
Calculation as of: 2026-10-06T19:43:51.134Z.
Quote observation: 2026-10-06T19:40:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f69dda8f3330533b5b8c72b5a53e0a0a6fa28851440bc7cc40968d1f378f11ab
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2021-09-30.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
N/A
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$210.80M
EV/FCF Ratio
N/A
TTM Avg
3.80x
3Y Avg
3.80x
5Y Avg
3.80x
Market Cap
$208.48M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$200.38M
EV/FCF Ratio
N/A
TTM Avg
7.28x
3Y Avg
7.28x
5Y Avg
7.28x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Whitehawk Therapeutics Inc (WHWK) | $205.80M | N/A | N/A | N/A | N/A |
| Electra Therapeutics Inc. (ETRA)vs › | $206.40M | N/A | N/A | N/A | N/A |
| Pro-Dex, Inc. (PDEX)vs › | $207.70M | 31.57x | 29.35x | 31.54x | 30.56x |
| Surrozen, Inc. (SRZN)vs › | $203.00M | N/A | N/A | N/A | N/A |
| Entrada Therapeutics, Inc. (TRDA)vs › | $210.80M | N/A | 3.80x | 3.80x | 3.80x |
| Sionna Therapeutics, Inc. (SION)vs › | $210.17M | N/A | N/A | N/A | N/A |
| Compugen Ltd. (CGEN)vs › | $210.85M | N/A | N/A | N/A | N/A |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $208.48M | N/A | N/A | N/A | N/A |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $200.38M | N/A | 7.28x | 7.28x | 7.28x |
| Exagen Inc. (XGN)vs › | $199.99M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2021-09-30 | 570.48x |
| 2021-09-29 | 575.16x |
| 2021-09-28 | 573.60x |
| 2021-09-27 | 584.13x |
| 2021-09-24 | 619.03x |
| 2021-09-23 | 628.19x |
| 2021-09-22 | 634.63x |
| 2021-09-21 | 581.01x |
| 2021-09-20 | 565.02x |
| 2021-09-17 | 570.09x |
| 2021-09-16 | 550.60x |
| 2021-09-15 | 547.67x |
| 2021-09-14 | 541.63x |
| 2021-09-13 | 542.99x |
| 2021-09-10 | 542.21x |
| 2021-09-09 | 534.61x |
| 2021-09-08 | 537.34x |
| 2021-09-07 | 514.14x |
| 2021-09-03 | 535.78x |
| 2021-09-02 | 550.40x |
| 2021-09-01 | 531.10x |
| 2021-08-31 | 505.76x |
| 2021-08-30 | 495.42x |
| 2021-08-27 | 504.78x |
| 2021-08-26 | 641.25x |
| 2021-08-25 | 647.10x |
| 2021-08-24 | 650.03x |
| 2021-08-23 | 647.10x |
| 2021-08-20 | 623.71x |
| 2021-08-19 | 625.27x |
| 2021-08-18 | 635.40x |
| 2021-08-17 | 670.50x |
| 2021-08-16 | 600.31x |
| 2021-08-13 | 650.03x |
| 2021-08-12 | 606.16x |
| 2021-08-11 | 588.61x |
| 2021-08-10 | 588.61x |
| 2021-08-09 | 620.78x |
| 2021-08-06 | 600.31x |
| 2021-08-05 | 594.46x |
| 2021-08-04 | 582.77x |
| 2021-08-03 | 588.61x |
| 2021-08-02 | 597.39x |
| 2021-07-30 | 588.61x |
| 2021-07-29 | 617.86x |
| 2021-07-28 | 629.56x |
| 2021-07-27 | 603.24x |
| 2021-07-26 | 617.86x |
| 2021-07-23 | 603.24x |
| 2021-07-22 | 609.09x |
| 2021-07-21 | 632.48x |
| 2021-07-20 | 585.69x |
| 2021-07-19 | 576.92x |
| 2021-07-16 | 600.31x |
| 2021-07-15 | 585.69x |
| 2021-07-14 | 597.39x |
| 2021-07-13 | 632.48x |
| 2021-07-12 | 746.53x |
| 2021-07-09 | 728.99x |
| 2021-07-08 | 813.79x |
| 2021-07-07 | 497.96x |
| 2021-07-06 | 509.66x |
| 2021-07-02 | 509.66x |
| 2021-07-01 | 512.58x |
| 2021-06-30 | 225.09x |
| 2021-06-29 | 221.07x |
| 2021-06-28 | 239.84x |
| 2021-06-25 | 245.20x |
| 2021-06-24 | 239.84x |
| 2021-06-23 | 231.79x |
| 2021-06-22 | 239.84x |
| 2021-06-21 | 241.18x |
| 2021-06-18 | 249.22x |
| 2021-06-17 | 249.22x |
| 2021-06-16 | 261.29x |
| 2021-06-15 | 247.88x |
| 2021-06-14 | 263.97x |
| 2021-06-11 | 276.03x |
| 2021-06-10 | 273.35x |
| 2021-06-09 | 278.71x |
| 2021-06-08 | 263.97x |
| 2021-06-07 | 246.54x |
| 2021-06-04 | 251.90x |
| 2021-06-03 | 243.86x |
| 2021-06-02 | 253.24x |
| 2021-06-01 | 226.43x |
| 2021-05-28 | 226.43x |
| 2021-05-27 | 222.41x |
| 2021-05-26 | 225.09x |
| 2021-05-25 | 225.09x |
| 2021-05-24 | 231.79x |
| 2021-05-21 | 269.33x |
| 2021-05-20 | 273.35x |
| 2021-05-19 | 296.14x |
| 2021-05-18 | 262.63x |
| 2021-05-17 | 221.07x |
| 2021-05-14 | 154.04x |
| 2021-05-13 | 141.97x |
| 2021-05-12 | 154.04x |
| 2021-05-11 | 136.61x |
| 2021-05-10 | 136.61x |
| 2021-05-07 | 139.29x |
| 2021-05-06 | 139.29x |
| 2021-05-05 | 143.31x |
| 2021-05-04 | 147.34x |
| 2021-05-03 | 152.70x |
| 2021-04-30 | 156.72x |
| 2021-04-29 | 155.38x |
| 2021-04-28 | 156.72x |
| 2021-04-27 | 155.38x |
| 2021-04-26 | 158.06x |
| 2021-04-23 | 152.70x |
| 2021-04-22 | 152.70x |
| 2021-04-21 | 146.00x |
| 2021-04-20 | 144.66x |
| 2021-04-19 | 147.34x |
| 2021-04-16 | 159.40x |
| 2021-04-15 | 159.40x |
| 2021-04-14 | 166.10x |
| 2021-04-13 | 166.10x |
| 2021-04-12 | 168.79x |
| 2021-04-09 | 179.51x |
| 2021-04-08 | 183.53x |
| 2021-04-07 | 176.83x |
| 2021-04-06 | 172.81x |
| 2021-04-05 | 172.81x |
| 2021-04-01 | 170.13x |
